Accelerate Diagnostics Inc (AXDX)

Feb 21, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World

Feb 21, 2025

Feb 13, 2025

StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World

Feb 13, 2025

Feb 11, 2025

Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire

Feb 11, 2025

Feb 08, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Armenian Reporter

Feb 08, 2025

Feb 07, 2025

Axos Invest Inc. Purchases 54,293 Shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) - Armenian Reporter

Feb 07, 2025

Feb 07, 2025

Antimicrobial Susceptibility Testing Market Advancements Highlighted by Analysis and Forecast to 2033: Mark... - WhaTech

Feb 07, 2025

Feb 06, 2025

Indaba Capital Management, L.P. Acquires Significant Stake in Ac - GuruFocus.com

Feb 06, 2025

Feb 06, 2025

BD to separate biosciences and diagnostics business - BioWorld Online

Feb 06, 2025

Feb 03, 2025

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Projected to Reach USD 6.5 Billion by 2035 at a 4.2% of CAGR | Future Market Insights, Inc. - Morningstar

Feb 03, 2025

Jan 31, 2025

Global Antimicrobial Resistance Surveillance Market to Reach USD 9.50 Billion by 2032, Growing at a CAGR of 5.47% - WICZ

Jan 31, 2025

Jan 30, 2025

Accelerate Diagnostics faces Nasdaq delisting risk By Investing.com - Investing.com South Africa

Jan 30, 2025

Jan 30, 2025

Accelerate Diagnostics faces Nasdaq delisting risk - Investing.com

Jan 30, 2025

Jan 28, 2025

Global Antimicrobial Susceptibility Testing Market to Reach USD 4.8 Billion by 2035, Growing at a CAGR of 3.6% | Future Market Insights, Inc. - GlobeNewswire Inc.

Jan 28, 2025

Jan 28, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World

Jan 28, 2025

Jan 28, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Now Covered by Analysts at StockNews.com - Defense World

Jan 28, 2025

Jan 12, 2025

StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World

Jan 12, 2025

Jan 11, 2025

Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million - MSN

Jan 11, 2025

Jan 10, 2025

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PR Newswire

Jan 10, 2025

Jan 08, 2025

Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test - Business Wire

Jan 08, 2025

Jan 07, 2025

GRIFFIN ASSET MANAGEMENT, INC. Reduces Holdings in Accelerate Di - GuruFocus.com

Jan 07, 2025

Jan 06, 2025

Aptitude Secures $10M+ to Accelerate Development of Point-of-Care and Over-the-Counter CT/NG/TV STI Test on Metrix® Platform - PR Newswire

Jan 06, 2025

Jan 04, 2025

Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 04, 2025

Jan 02, 2025

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World

Jan 02, 2025

Dec 31, 2024

Accelerate Diagnostics (AXDX) – Investment Analysts’ Weekly Ratings Changes - Defense World

Dec 31, 2024

Dec 19, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 19, 2024

Dec 19, 2024

Antimicrobial Susceptibility Testing Market Outlook & Trends 2024: Global Forecast & Insights - WhaTech

Dec 19, 2024

Dec 17, 2024

Antimicrobial Susceptibility Testing Market Analysis - openPR

Dec 17, 2024

Dec 09, 2024

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - Yahoo Finance

Dec 09, 2024

Dec 06, 2024

ACEL Stock Hits 52-Week High at $12.62 Amid Market Optimism - Investing.com UK

Dec 06, 2024

Dec 06, 2024

ACEL Stock Hits 52-Week High at $12.62 Amid Market Optimism By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 03, 2024

Accelerate Diagnostics director John Patience buys $314k in common stock - Investing.com Nigeria

Dec 03, 2024

Dec 03, 2024

Accelerate Diagnostics director Jack Schuler sells $314,000 in stock By Investing.com - Investing.com Nigeria

Dec 03, 2024

Dec 03, 2024

Accelerate Diagnostics director Jack Schuler sells $314,000 in stock - Investing.com India

Dec 03, 2024

Nov 27, 2024

Accelerate Diagnostics (NASDAQ:AXDX) Raised to “Hold” at StockNews.com - Defense World

Nov 27, 2024

Nov 25, 2024

Glox Therapeutics awarded grant to accelerate development of precision antibiotics - European Pharmaceutical Manufacturer

Nov 25, 2024

Nov 23, 2024

Microbial Identification Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031 - WhaTech

Nov 23, 2024

Nov 22, 2024

Sepsis Diagnostics Market To Grow at 8.5% By 2032Market.us Media - Market.us Media - United States Market News

Nov 22, 2024

Nov 15, 2024

Armistice Capital, LLC's Strategic Acquisition in Accelerate Dia - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

William Blair Has Bearish Estimate for AXDX FY2024 Earnings - Defense World

Nov 15, 2024

Nov 11, 2024

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Nov 11, 2024

GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology - BioSpace

Nov 11, 2024

Nov 09, 2024

Next-generation rapid phenotypic antimicrobial susceptibility testing - Nature.com

Nov 09, 2024

Nov 09, 2024

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 09, 2024

Nov 08, 2024

Accelerate Diagnostics: Q3 Earnings Snapshot - Houston Chronicle

Nov 08, 2024

Nov 08, 2024

Accelerate Diagnostics Reports Key Advances Amid Financial Challenges - TipRanks

Nov 08, 2024